INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 5,070.00
-190.00 (-3.61%)
At close: Sep 11, 2026
INBIOGEN Market Cap
INBIOGEN has a market cap or net worth of 50.62 billion as of September 11, 2026. Its market cap has decreased by -60.73% in one year.
Market Cap
50.62B
Enterprise Value
52.33B
Revenue
5.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,070.00
ChartMarket Cap Chart
Since August 14, 2008, INBIOGEN's market cap has decreased from 218.39B to 50.62B, a decrease of -76.82%. That is a compound annual growth rate of -7.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 50.62B | -51.67% |
| Dec 30, 2025 | 104.74B | 103.00% |
| Dec 29, 2022 | 51.60B | -72.31% |
| Dec 30, 2021 | 186.34B | -26.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JS Corporation | 374.90B |
| Au Brandz Co.,Ltd | 216.39B |
| BAIKSAN Co,. | 215.90B |
| Hwaseung Enterprise | 171.77B |
| SYTS Corp. | 141.04B |
| HWASEUNG Industries | 115.25B |
| Nine & Company | 105.57B |
| Uni-Chem | 38.96B |